HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Enforma To Cease Deceptive Weight Loss Claims, Pay $10 Mil. -FTC

This article was originally published in The Tan Sheet

Executive Summary

Enforma Natural Products settles Federal Trade Commission charges that it made false and unsubstantiated weight loss claims in an infomercial and on the Internet, without admitting a violation of law, the agency announces April 26.

You may also be interested in...



Enforma Carb Trapper Plus Supplement Ad Claims Under FTC Scrutiny

Enforma Natural Products could be hit with civil contempt charges for the third time if FTC determines the firm is making unsubstantiated advertising and marketing claims for its Carb Trapper Plus weight-loss product

TechnoBrands Will Cease Misleading Ad Claims, Pay $200,000 Fine – FTC

TechnoBrands, Inc. has agreed to pay $200,000 to settle Federal Trade Commission charges the firm made false and unsubstantiated claims for several products, including two weight-loss supplements and a hair regrowth stimulant

FTC sues Enforma

Civil contempt charges filed by FTC Jan. 3 against Enforma Natural Products; hearing is scheduled for Feb. 4 in Los Angeles federal court. Commission alleges Enforma "blatantly disregarded" a May 2000 order by continuing to make unsubstantiated claims about its Fat Trapper Plus and Exercise In A Bottle weight-loss products (1"The Tan Sheet" May 1, 2000, p. 17). FTC requests order requiring defendants cease use of trade names Fat Trapper, Fat Trapper Plus and Exercise in a Bottle, and turn over all gross revenues from sale of products at issue since May 2000...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133775

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel